CINC - CinCor Pharma GAAP EPS of -$0.56 misses by $0.08
- CinCor Pharma press release ( NASDAQ: CINC ): Q2 GAAP EPS of -$0.56 misses by $0.08 .
- Cash, cash equivalents and marketable securities totaled $294.3 million as of June 30, 2022, as compared to $136.6 million as of December 31, 2021.
- Shares +28% PM
For further details see:
CinCor Pharma GAAP EPS of -$0.56 misses by $0.08